← Back to screener

ORTHOPEDIATRICS CORP KIDS

Rank #1858 · Nasdaq · $0.8B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
40.4
P/E
-37.8
P/B
2.09
ROE
-5.5%
Op. Margin
-18.0%
Debt Ratio
31%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E -37.8x, P/B 2.09x. Ranks in the top 56% of the universe.

Profitability ★☆☆☆☆
Weak

ROE -5.5%. Ranks in the top 77% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 31%. Ranks in the top 17% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★☆
Excellent

Revenue growth of 21.6% year over year. Ranks in the top 17% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2017$0.0B$-0.0B$-0.0B$-0.0B-21.3-58
2018$0.0B$-0.0B$-0.0B$-0.1B-16.4-64
2019$0.0B$-0.0B$-0.0B$-0.1B-14.2-47
2020$0.1B$-0.0B$-0.0B$0.0B-16.684
2021$0.1B$-0.0B$-0.0B$0.1B-12.5105
2022$0.1B$-0.0B$-0.0B$0.1B-37.655
2023$0.1B$-0.0B$-0.0B$0.2B-18.421
2024$0.1B$-0.0B$0.0B$0.2B-20.827
2025$0.1B$-0.0B$-0.0B$0.4B-18.031

← See the full screener